U.K. Vaccination Surge Adds to Trade Tensions: Brexit Bulletin

What’s happening? A Brexit-tinged vaccine row, and London financiers feel the squeeze.

Brexit Britain’s vaccine rollout is surging ahead of the European Union’s, opening a new front in tensions between the former partners. Positive trial data for Novavax’s Covid-19 shot – of which the U.K. has ordered 60 million doses – came as the EU prepared an export ban and continued its week-long row with drugmaker AstraZeneca PLC over its vaccine supply. Yet, as Kitty Donaldson and Joe Mayes reported, there is confidence in London that drugmakers Pfizer Ltd. and AstraZeneca Plc see no interruption to deliveries destined for Britain.

It’s a different story ...